Life Sciences

20 Mar 2019  |  North America  |  Mega Trends

Growth Opportunities in the North American Clinical Laboratory Services Market, Forecast to 2022

Laboratories Seek Alternate Revenue Streams to Combat Reimbursement Pressure

Infographics

×

Clinical laboratory services represent one of the highest healthcare expenditures in North America, yet the United States and Canada represent different scenarios in the way clinical services are rendered. The market for clinical lab services in Canada was an estimated $10.33 billion in 2017 whereas in the United States it was an estimated $78.33 b...

14 Jan 2019  |  North America  |  Mega Trends

Growth Opportunities in the Global qPCR and dPCR Market, Forecast to 2023

Novel Applications in Oncology and Applied Sciences, Growing Research and Diagnostic Use in Developing Regions, and Automated Modular Workflows to Drive Growth

Infographics

×

Key Issues Addressed

Overview: PCR continues to be the gold standard for nucleic acid amplification by combining accuracy and efficacy that users across areas such as research, pharma & biotech, diagnostics as well as applied sciences depend upon. Such widespread usage continues to drive the industry, even protecting it to some extent from overall economic/market fluct...

In an increasingly convergent industry such as healthcare, business collaborations are not only a necessity, but an inevitability. It is interesting to note that technologies and market segments that receive the most funding and research focus, are also the areas that are ripe for collaborative partnerships. Market segments such as personalized med...

The research service aims to give a global outlook of the companion diagnostic market landscape, with a specific focus on Western European countries. The segments related to oncology discussed in this study include breast cancer, lung cancer, colorectal cancer and other cancers, and non-oncology related infectious disease, CNS, and cardiovascular. ...

Monoclonal antibody therapeutics are being used for treatment of a wide array of diseases, specially in therapeutic areas such as oncology, immunology (including autoimmune and inflammatory diseases, as well as, transplant rejection) and neuroscience. The development of these new molecular agents, successfully directed to specific cellular targets,...

This research service focuses on the current status of candidates for opioid therapeutics with a focus on current Phase 3 candidates, detailed timelines, rational for pivotal program design, Phase 2 data review and key opinion leader (KOL) commentary. A pipeline assessment is provided for all active candidates in development. The information contai...

With the growing need for better therapeutics, and the current patent cliff that is underway, therapies such as monoclonal antibodies, recombinant protein therapeutics and even vaccines for a whole host of indications are in high demand. Conventionally expression systems were utilized to aid in the development and production of these therapeutics...

Technical Insights division of Frost & Sullivan evaluated technology trends in the Health and Wellness sector and has identified top technology trends that are likely to have an impact in the year 2015. The research service provides an in depth analysis of the top 10 health and wellness technologies that are anticipated to have the highest impact a...